Cite Filings / CMPX / 0001171843-23-000446

Feed Companies Filings Check

Sign in

424B3

Prospectus

Compass Therapeutics, Inc. Filed 2023-01-24 Acc 0001171843-23-000446

Documents 1

424B3 Prospectus , cmpx20230124_424b3.htm

Around this filing

2023-01-24 424B3 Prospectus
2023-01-24 4 CHIEF EXECUTIVE OFFICER bought 20,000 shares at $4.19 ($83,800)
2023-01-20 EFFECT Notice of Effectiveness
2023-01-19 CORRESP Correspondence Between Filers and SEC Staff
2023-01-19 8-K Other events
2023-01-17 CORRESP Correspondence Between Filers and SEC Staff
2021-04-30 424B3 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading cmpx20230124_424b3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…